NIH-funded research NIH-funded research

Can cancer cachexia be reversed by targeting body-wide metabolic signals?

Official title: CANCAN - Kaiser

Funded at Kaiser Foundation Research Institute · NIH-11539619 · Data updated 2026-11-12

Researchers at Kaiser are exploring how cancer-related weight and muscle loss (cachexia) happens and whether new approaches can improve appetite, metabolism, and tissue health for people with cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionKaiser Foundation Research Institute
NIH-funded
Lab location1 site (Oakland, UNITED STATES)
Project startJune 22, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$973,898
NIH project number3OT2CA278691-01S4
Project IDNIH-11539619 on NIH RePORTER

Who could benefit from this research

Could help

Adults with cancer who experience or are at risk of cancer cachexia and are pursuing standard cancer care.

Less likely to help

Patients without cancer cachexia or those not receiving treatments where cachexia-targeted therapies would be applicable may not benefit.

What this research studies

Cancer cachexia is a serious condition where patients lose weight and muscle because of cancer. This project brings together international experts to study how tumors communicate with the body to cause anorexia and tissue wasting, using advanced metabolic tracing and imaging to map host-tumor interactions. The team aims to identify upstream mediators and develop high-quality discovery science that could lead to new therapies and better clinical phenotyping of cachexia. By understanding these pathways, they hope to improve quality of life, treatment tolerance, and survival for patients facing cancer.

Why it matters

Potential benefit: If successful, this work could pave the way for new treatments that reduce weight and muscle loss in cancer patients and improve outcomes.

How similar studies have gone: Previous studies have advanced knowledge of cachexia pathways, but effective upstream targets and therapies remain to be established, making this an exploratory yet linked step forward.

Where this research is happening

  • Kaiser Foundation Research Institute
    Oakland, United States
    Active

Researchers

  • Principal investigator: Feliciano, Elizabeth Marjorie Cespedes — Kaiser Foundation Research Institute
  • Study coordinator: Feliciano, Elizabeth Marjorie Cespedes

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.